Document Detail


Autonomic side effects of Botulinum toxin Type B intravesical injections: report of 4 cases and review of the literature.
MedLine Citation:
PMID:  17136583     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Recently, intravesical injections of Botulinum toxin type B (BT-B) have been trialled in an attempt to treat detrusor overactivity. Use of Botulinum toxin A (BT.-A), for the same in the past, has been quite successful without many reported side effects. Soon after commencing the clinical use of BT-B, a side effect profile was noticed not reported with BT-A. A total of 20 patients with refractory detrusor overactivity were included in this randomized, double blind, placebo controlled, cross over trial. As per protocol, 5000 MU (1 ml) BT-B diluted to a volume of 20 mls with normal saline were injected in 10 different sites into the detrusor, sparing the trigone. We report four cases of autonomic side effects after these injections which strongly suggest clinically relevant systemic spread of the toxin.
Authors:
M Ghei; B H Maraj; S Nathan; J Malone-Lee; R Miller
Related Documents :
19896973 - The role of antihistaminic effects in the misuse of quetiapine: a case report and revie...
15055653 - Orofacial complications associated with forward repositioning of the mandible in snore ...
3565453 - Adrenal hemangioblastoma in von hippel-lindau disease as a cause of secondary erythrocy...
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  International urology and nephrology     Volume:  38     ISSN:  0301-1623     ISO Abbreviation:  Int Urol Nephrol     Publication Date:  2006  
Date Detail:
Created Date:  2007-02-23     Completed Date:  2007-09-07     Revised Date:  2013-11-25    
Medline Journal Info:
Nlm Unique ID:  0262521     Medline TA:  Int Urol Nephrol     Country:  Hungary    
Other Details:
Languages:  eng     Pagination:  543-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Intravesical
Adult
Aged
Autonomic Nervous System Diseases / chemically induced*
Botulinum Toxins / administration & dosage*,  pharmacology*
Female
Humans
Male
Middle Aged
Chemical
Reg. No./Substance:
0Y70779M1F/rimabotulinumtoxinB; EC 3.4.24.69/Botulinum Toxins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dilemmas in the management of female stress incontinence: the role of pelvic floor muscle training.
Next Document:  Spontaneous bladder rupture caused by a giant vesical calculus.